We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
The Cheeky Panda (TCP) is a B Corp that offers a range of sustainable bamboo tissue and hygiene products available across Europe, the USA, China, and the Middle East. It asserts that its products are on the shelves of some of the World's top retailers including, Waitrose, Boots, MonoPrix and Carrefour. The company has sold over 12 million products across 25 countries and aims to become a contender in the overall hygiene market that is valued at over $200 billion a year. TCP featured in Sunday Times 'Fast Track – 'Ones to Watch' list, won Ocados rising stars best plant-based product in 2021, and launched with Waitrose in over 200 stores. TCP will use the investment to strengthen its management team in the run-up to IPO, focus on marketing and brand awareness to grow D2C sales, and oversee product launches with major retailers.
days to go: Expired investment: £2,400,550
Taska is a fishing tackle brand that has been producing its own products since 2011. In 2017, it was acquired by LetsGetFishing LTD. Taska develops and designs its own products, and currently, it has over 400 products available. It aims to expand and launch its products into European markets by engaging with retailers/wholesalers via trade shows. It has built over 141,000 Facebook followers in the UK. Taska believes that it can replicate its social media success in the European market and organically grow sales through product savvy anglers. In the last 12 months, Taska had £1,000,000+ sales with a Net Profit of £9400.
days to go: Expired investment: £69,560
Please watch the video for more information
days to go: Expired investment: £964,550
TransferGuru is an online money transfer platform that allows users to send money to friends or family all across the world. TransferGuru offer an exchange rate comparison service that allows the user to see all of the providers in their chosen country. 
days to go: Expired investment: £46,746
Forth allows users to track their wellbeing to see what impact their lifestyle is having on their health. It allows users to maximise their performance during athletics, keep track of their inner health and focus on things they may need to work on for greater overall wellbeing. 
days to go: Expired investment: £165,760
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph